Proliferation and differentiation of hematopoietic stem/progenitor cells (HSPC) within bone marrow (BM) niches are regulated by adhesion molecules and cytokines produced by mesenchymal stem/progenitor cells (MPC) and osteoblasts (OB). HSPCs that egresses to peripheral blood are widely used for transplant and granulocyte-colony stimulating factor (G-CSF) is used clinically to induce mobilization. The mechanisms, through which G-CSF regulates HSPC trafficking, however, are not completely understood. Herein we show that G-CSF-driven neutrophil expansion alters the BM niche that leads to HSPC mobilization. Alcam À Sca-1 þ MPC and Alcam þ Sca-1 À OB are reduced coincident with mobilization, which correlates inversely with BM neutrophil expansion. In mice made neutropenic by the neutrophil-specific anti-Ly6G antibody, G-CSF-mediated reduction in MPC and OB is attenuated and mobilization reduced without an effect on monocytes/macrophages. Neutrophils, expanded in response to G-CSF-induced MPC and OB apoptosis leading to reduced production of BM HSPC retention factors, including stromal cell-derived factor-1, stem cell factor and vascular cell adhesion molecule-1. Blockade of neutrophil reactive oxygen species attenuates G-CSF-mediated MPC and OB apoptosis. These data show that the expansion of BM neutrophils by G-CSF contributes to the transient degradation of retention mechanisms within the BM niche, facilitating enhanced HSPC egress/mobilization.
INTRODUCTION
In adults, hematopoietic stem and progenitor cells (HSPC) are localized in specialized niches along the endosteal bone surface, [1] [2] [3] or in perivascular sites adjacent to the endothelium, [4] [5] [6] where they undergo self-renewal and differentiation, giving rise to all mature blood cells. The endosteal niche is composed primarily of mesenchymal stem/progenitor cells (MPC) and their progeny, which express numerous adhesion molecules and produce supportive cytokines, chemokines and other bioactive molecules essential for HSPC retention within the bone marrow (BM). 7, 8 At steady state, a small number of HSPC circulate in the peripheral blood (PB), [9] [10] [11] however, agents with distinct cellular targets, including hematopoietic growth factors, cytokines and chemokines, can enhance HSPC trafficking to PB, a process termed mobilization. [12] [13] [14] Mobilized peripheral blood stem cells (PBSC) are the primary source of HSPC for clinical hematopoietic transplantation and granulocyte-colony stimulating factor (G-CSF) is widely used clinically for PBSC mobilization 13 Evidence suggests that G-CSF-induced HSPC mobilization involves a complex interaction of mechanisms, resulting in endosteal niche attenuation and HSPC egress to the periphery. 5, 12, 15, 16 Soluble factors has a crucial role in HSPC retention in BM and include the interactions of stromal cell-derived factor-1 (SDF-1) with its receptor CXCR4 expressed on HSPC and stromal vascular cell adhesion molecule-1 (VCAM-1) with very late antigen 4 (VLA-4), which tether HSPC within the BM. Disruption of these axes induces HSPC mobilization. [17] [18] [19] Earlier studies suggested that G-CSF-mediated HSPC mobilization was a consequence of proteolytic degradation of SDF-1 and VCAM-1 by serine and metallo-proteases primarily derived from polymorphonuclear neutrophils, [20] [21] [22] [23] however, the physiological role of these proteases remains unclear. 24 More recently, inhibition of MPC proliferation and osteoblast (OB) apoptosis by G-CSF has been implicated in HSPC mobilization, 5, 16, 25 which is at least partly mediated through sympathetic nervous system signaling. 26 Bone-marrow monocytes/ macrophages provide positive support to osteolineage cells with the BM niche and reduction of this support in response to G-CSF results in HSPC mobilization. [27] [28] [29] However, as G-CSF-induced HSPC mobilization is only partially reduced in monocyte/ macrophage-depleted mice, it is likely that G-CSF also acts on other contributing cell types.
The fact that G-CSF treatment induces a robust expansion of BM and PB neutrophils and that G-CSF receptor deficient mice, which are neutropenic, show impaired G-CSF-induced HSPC mobilization despite normal HSPC number and function, suggest that neutrophils are involved in G-CSF-induced HSPC mobilization. 30 In this study, we demonstrate that neutrophils contribute significantly to G-CSF-induced mobilization of HSPC by reducing the number of BM MPC and OB and expression of factors involved in HSPC retention.
G-CSF treatment and preparation of cell suspensions
Peripheral blood HSPC mobilization was induced by treating mice with 1 mg/mouse recombinant human G-CSF (NEUPOGEN; Amgen Inc., Thousand Oaks, CA, USA) s.c. twice daily for 3 days (50 mg/kg, bid Â 3 days). For some experiments mice were treated with the antioxidant N-acetyl-lcystein (NAC; Sigma-Aldrich, St Louis, MO, USA) (s.c. at 50 mg/kg) and G-CSF together. Mice were killed 16 h after the last G-CSF injection and PB was obtained by cardiac puncture and placed in EDTA microtainers (BD Biosciences, San Diego, CA, USA). Total blood counts were determined using a Hemavet hematology analyzer with veterinary software (Drew Scientific Inc., Waterbury, CT, USA). BM cells were harvested by flushing femurs with a-modified Eagle medium (Lonza Inc., Allendale, NJ, USA) containing 2% fetal bovine serum (Thermo Scientific HyClone, Logan, UT, USA). The extracellular fluid in each femur was obtained by flushing with 1 ml ice-cold PBS followed by centrifugation at 400 Â g for 3 min and collection of cell-free supernatant.
Neutrophil depletion in vivo
To determine the role of neutrophils in G-CSF-induced mobilization, mice were treated with anti-Gr-1 antibody (RB6-8C5 clone; eBiosciences, San Diego, CA, USA) or anti-Ly6G antibody (1A8 clone; BioLegend, San Diego, CA, USA) (both at 150 mg/mouse) on day 1 of a 3 day G-CSF treatment regimen. Control mice were treated with isotype antibody.
Competitive repopulation assay
Transplantable long-term PB hematopoietic stem cells (HSC) were quantitated by competitive repopulation transplantation analysis. Recipient congenic CD45.1/CD45.2 F1 hybrid mice were lethally irradiated with 11.0 Gy in two split doses B5 h apart. Twenty-hours after irradiation mice were injected by tail vein with 50 ml RBC-lysed blood samples from G-CSF mobilized normal mice or neutrophil-depleted CD45.2 þ CD57BL/six mice (five mice/group) plus 200 000 competitive whole BM cells from untreated CD45.1 þ BoyJ mice (in a total volume of 200 ml). Recipient mice were maintained on doxycycline feed for 1 month post-transplant. Chimerism in PB was determined at 6 months post-transplant and SLAM-LSK cell number in BM, defined as Lineage À (CD3 À Gr-1 À CD11b À CD45R À Ter119 À ) Sca-1 þ c-Kit þ CD150 þ CD48 À , was determined by flow-cytometry.
Neutrophil isolation and co-culture with OB precursors/OBs BM cells were stained with FITC-conjugated anti-Ly6G antibody, APC-Cy7conjugated anti-CD11b antibody, PE-conjugated anti-F4/80 antibody, APCconjugated anti-CD115 and Ly6G þ CD115 À F4/80 À (Ly6G þ ) neutrophils or Ly6G À non-neutrophil cells were sorted by fluorescence-activated cell sorting (FACS). All antibodies were purchased from BD Biosciences or eBiosciences. Dead cells were excluded with LIVE/DEAD Fixable Violet Dead Cell Staining dye (Invitrogen, Carlsbad, CA, USA). The mouse pre-OB MC3T3-E1 cell line (American Type Culture Collection, Manassas, VA, USA) was maintained in a humidified 5% CO 2 atmosphere at 37 1C in a-modified Eagle medium containing 10% fetal bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin and 1 mM sodium pyruvate. In order to induce differentiation of MC3T3-E1 cells into OB, cells were plated at 2 Â 10 5 cells/ well in six-well plates or 4 Â 10 4 cells/well in 12-well plates in a-modified Eagle medium with 10% fetal bovine serum supplemented with 50 mg/ml ascorbic acid and 10 mM b-glycerol phosphate for 1-10 days (plating day was considered as day 0). For co-culture experiments, FACS sorted Ly6G þ neutrophils or Ly6G À cells (2 Â 10 6 cells) were added to pre-OB MC3T3-E1 or differentiated MC3T3-E1 OB monolayers (2 Â 10 5 cells) and cultured with G-CSF for 3 days. At the end of the incubation period cells were stained with UV-violet fluorescence reactive dye and lineage cocktail antibodies and followed by Annexin V staining (BD Biosciences). Viability of pre-OB/ OB was determined by flow-cytometry. Co-culture supernatants were collected for ELISA analysis.
Quantitative PCR
Total RNA was purified with Purelink RNA mini Kit and reverse transcribed with SuperScript III First-Strand Synthesis System for (Invitrogen, Grand Island, NY, USA) RT-PCR. Primers for mouse actin, SDF1 and VCAM1 were designed to produce an amplicon size of 100 to 150 bp and synthesized by Integrated DNA Technologies (Coralville, IA, USA). Sequences of the primers were: Actin F-AGGTGTGCACCTTTTATTGGTCTCAA; Actin R-GTAGTAAGGTTTGGTCTCCCT.
SDF1-R-TTCTTCAGCCGTGCAACAATC; SDF1-F-TGCATCAGTGACGGTAAACCA. VCAM1-F-GACCTGTTCCAGCGAGGGTCTA; VCAM1-R-CTTCCATCCTCATAGCAATTAAGGTG.
QRT-PCR was performed by using SYBR advantage qPCR Premix kit (Clontech, Mountain View, CA, USA) on MxPro-3000 (Agilent, La Jolla, CA, USA). All experiments were performed in triplicates.
ELISA SDF-1 and stem cell factor (SCF) levels in BM extracellular fluid and SDF-1 in culture supernatants were quantitated using R&D Systems Duo set ELISA kits according to the manufacturer's instructions (R&D Systems, Minneapolis, MN, USA).
Statistical analysis
Data are presented as X±s.e.m. Statistical significance was assessed using a two-tailed Student's t-test.
RESULTS
G-CSF-induced HSPC mobilization is impaired in neutrophil ablated mice Mobilization by G-CSF is known to be a two compartment model mediated by trans acting signals affecting accessory cell populations. As G-CSFR is expressed at high levels on mature and immature neutrophils and at an intermediate level on monocytes/ macrophages, B cells and NK cells, it is likely that one or more of these cell types are involved in G-CSF-induced HSPC mobilization.
We have previously shown that neutrophil depletion reduces mobilization of myeloid colony-forming cells and radioprotective cells. 23 To further define a role for neutrophils in G-CSF-induced HSPC mobilization, we evaluated HSPC number and function in neutrophil depleted mice. As we previously described, 23 a 3 day regimen of G-CSF (100 mg/kg) significantly increases the proportion of Ly6G þ CD115 À BM neutrophils, while administra tion of monoclonal anti-Gr-1 antibody at the time of initiation of the G-CSF mobilization regimen reduces Ly6G þ CD115 À cells by X60% ( Figure 1a ) and circulating neutrophils by 98% (data not shown). Manual differential counts performed to exclude interference of in vivo anti-Gr-1 treatment with FITC-labeled anti-Gr-1 used for flow cytometry analysis confirmed the expansion of BM neutrophils by G-CSF and the reduction in total BM polymorphonuclear neutrophil by anti-Gr-1 antibody treatment (Figure 1a insert). In control mice, G-CSF administration induced robust mobilization of HSC-enriched SLAM LSK and LSK cells enriched for multipotent progenitor cells; however, mobilization of circulating SLAM LSK and LSK cells was significantly attenuated in neutropenic mice ( Figure 1b ). The magnitude of HSPC mobilization directly correlated with the absolute number of BM neutrophils (Figure 1c ). While G-CSF-induced mobilization was significantly reduced in neutropenic mice, neutrophil depletion did not affect the increase in SLAM LSK and LSK cells in the BM normally observed in response to G-CSF ( Figure 1d ). In fact, G-CSF-treated neutropenic mice had significantly more SLAM LSK cells than control mice. In competitive transplant studies, PB chimerism and BM SLAM LSK content at 6 months post transplant was significantly lower in mice transplanted with PB from G-CSF-mobilized neutropenic mice compared with G-CSF-mobilized PB from control mice (Figures 1e and f). These results suggest that the neutrophil population is required for optimal G-CSF-induced PBSC mobilization.
In vivo neutrophil depletion prevents G-CSF-mediated disruption of the osteolineage cells Long-term repopulating HSCs are localized in proximity to MPCand OB-enriched endosteal regions within the BM. 3 Previous studies have shown that G-CSF treatment decreases CD45 À CD31 À Ter119 À osteolineage endosteal cells 16, 25 and inhibits OB differentiation, 16 which may be responsible for increased HSC trafficking to PB. To examine the role of neutrophils in G-CSFmediated disruption of the cellular components of the endosteal niche, we first quantitated osteolineage cells in the BM of G-CSFtreated control and neutropenic mice. Similar to a previous report, 16 bone adjacent OB and CD45 À CD31 À Ter119 À osteolineage cells were substantially reduced in the BM of control mice after G-CSF treatment (Figure 2a ). However, in neutropenic mice, the reduction in osteolineage cells in response to G-CSF was significantly attenuated.
The BM CD45 À CD31 À Ter119 À osteolineage cell population is a heterogeneous population in terms of differentiation stage and function and can be divided into two subpopulations; the Sca-1 þ Alcam À fraction enriched for MPC and the Sca-1 À Alcam þ fraction enriched for OB. 3 G-CSF treatment substantially reduced both MPC and OB in the BM of control mice (Figure 2b ), but was significantly less effective in neutropenic mice.
Chemo-attracting cytokines, growth factors and adhesion molecules produced by the MPC and OB initiate signaling Neutrophil expansion disrupts the BM niche P Singh et al networks that regulate HSC retention in the BM 6, 31 and have been implicated in the mechanisms modulating HSPC mobilization particularly by G-CSF. 5, 16, 18 To examine whether neutrophils alter expression of these retention factors, we measured SDF-1, SCF and VCAM-1 mRNA expression and/or protein in the BM of G-CSF-treated control and neutropenic mice. SDF-1 and VCAM-1 mRNA expression were substantially decreased in CD45 À CD31 À Ter119 À cells from G-CSF-treated control mice, but were relatively unaffected in cells from neutrophil-depleted mice (Figure 2c ). While SDF-1 and SCF protein levels were significantly (Figure 2d ), in G-CSF-treated neutropenic mice their production was unchanged.
As the anti-Gr-1 monoclonal antibody (RB6-8C5) has been reported to also deplete some populations of monocytes, 32 we injected mice with the anti-Ly6G antibody (clone 1A8), which has been shown to specifically deplete neutrophils without affecting monocytes. 32 Co-treatment with anti-Ly6G during the G-CSF mobilization regimen, substantially depleted neutrophils in the BM of G-CSF-treated mice, however, the reduction of Ly6G À CD115 þ F4/80 int monocytes/macrophages was similar in G-CSFtreated control and in neutropenic mice (Figure 2e ). Similar to the affect seen with anti-Gr-1-dependent neutrophil depletion, the reduction in the CD45 À CD31 À Ter119 À cell number was significantly less in G-CSF and anti-Ly6G-treated neutropenic mice compared with G-CSF and control antibody treated mice (Figure 2f ), further confirming a role of neutrophils in the disruption of the endosteal BM niche by G-CSF.
Neutrophils directly inhibit osteolineage cell SDF-1 production in vitro
To determine whether neutrophils directly affect osteolineage progenitor cell and differentiated OB function, FACS sorted BM Ly6G þ CD115 À neutrophils or Ly6G À non-neutrophil cells were co-cultured with MC3T3 pre-OB cells or with differentiated OB, in the presence of G-CSF for 3 days and SDF-1 mRNA expression and SDF-1 protein levels in culture supernatant quantitated. Ly6G þ CD115 À neutrophils substantially reduced MC3T3 cell SDF-1 mRNA and protein production; whereas Ly6G À nonneutrophil cells had no significant effect (Figure 3a) . Similarly, Ly6G þ CD115 À neutrophils also impaired SDF-1 production from differentiated OB (Figure 3b ). As G-CSF treatment induces extensive neutrophil expansion, we next examined whether SDF-1 production from the osteolineage cells is affected by neutrophil cell number. FACS sorted Ly6G þ CD115 À BM neutrophils were co-cultured on MC3T3 pre-OB cell monolayers at different ratios in the presence of G-CSF. We hypothesized that if neutrophil expansion is important for the impairment of SDF-1 production from pre-OBs, then an increase in neutrophil number would dose dependently affect SDF-1 production. As shown in Figure 3c , increasing the number of neutrophils progressively reduced pre-OB SDF-1 production. These observations suggest that the G-CSF-mediated neutrophil expansion is likely responsible for impaired SDF-1 production in the BM. mice, FACS sorted Ly6G þ CD115 À or Ly6G À BM cells were co-cultured with MC3T3 pre-OB cells or MC3T3-derived differentiated OB in the presence of G-CSF and the cell viability of gated MC3T3 cells analyzed by Annexin-V staining. Ly6G þ CD115 À neutrophils significantly increased apoptosis of MC3T3 pre-OB ( Figure 4a ) and mature OB (Figure 4b ), while Ly6G À cells had no effect on survival. To further evaluate the role of neutrophils in regulating osteolineage cell apoptosis in response to G-CSF, we evaluated apoptosis in CD45 À CD31 À Ter119 Àgated BM cells from G-CSF-treated control mice and mice made neutropenic by anti-Ly6G administration. G-CSF substantially increased CD45 À CD31 À Ter119 À cell apoptosis in control mice as reported, 25 however, in neutropenic mice, CD45 À CD31 À Ter119 À cell apoptosis was unaffected (Figure 4c ), demonstrating that neutrophils mediate osteolineage cell apoptosis in response to G-CSF.
Reactive oxygen production by neutrophils is partially involved in osteolineage cell apoptosis Several studies have shown a role for reactive oxygen species (ROS) in the apoptosis of osteolineage cells [33] [34] [35] and inhibition of ROS signaling has been shown to reduce G-CSF-induced mobilization of HSPC. 36 As neutrophils induce osteolineage cell apoptosis, we evaluated whether ROS production by neutrophils was involved in this effect. Consistent with a previous report, 36 treatment of mice with the ROS inhibitor NAC significantly reduced G-CSF-induced HSPC mobilization (Figure 5a ). To determine whether neutrophils have a role in ROS production in BM, mice were treated with G-CSF and ROS was measured in BM neutrophils and non-neutrophil cells. BM neutrophils generated significantly higher levels of ROS compared with nonneutrophil cells and G-CSF treatment substantially increased neutrophil ROS production, whereas non-neutrophil ROS production was not changed (Figure 5b) . To examine the role of ROS in osteolineage cell apoptosis, we measured Annexin V expression in CD45 À CD31 À Ter119 À BM cells from G-CSF and G-CSF plus NAC-treated mice. G-CSF treatment substantially increased Annexin V expression in CD45 À CD31 À Ter119 --gated BM cells, however, treatment of mice with G-CSF and NAC together significantly reduced Annexin V expression ( Figure 5c ). These data link neutrophil-produced ROS in destruction of HSC niche components in the BM in response to G-CSF.
DISCUSSION
Although it is well established that deregulation of BM niche components is a primary cause for G-CSF-induced HSPC mobilization, lack of G-CSFR expression on MPC and their progeny that make up the HSC endosteal niche 16, 26 suggests the involvement of accessory cells and/or factors in this process. Although we have previously shown, 23 and confirmed herein, that neutrophils are important for HSPC mobilization induced by G-CSF, we now provide evidence that the expansion of neutrophils in the BM that occurs in response to G-CSF, induces MPC and OB apoptosis through increased ROS production and reduces the expression of MPC-and OB-derived factors crucial for HSC retention in the BM, including SDF-1, SCF and VCAM-1. These data provide new mechanistic insight into the role of accessory neutrophils in the PBSC mobilization process. Accumulating evidences suggest that the monocyte/ macrophage cell lineage has a role in HSPC retention in the BM and depletion of these cells induces HSPC trafficking. [27] [28] [29] The marrow niche contains supportive endosteal macrophages and G-CSF treatment reduces this population coincident with mobilization and OB suppression. Depletion of F4/80 þ Ly-6 G þ CD11b þ macrophages with clodronate-loaded liposomes also results in mobilization, but to a much lower extent compared with G-CSF. 27 Depletion of CD169 þ resident macrophages also impairs HSPCs BM retention 28 and expression of G-CSFR under the control of CD68 promoter, which restricts G-CSF receptor expression to the monocyte/macrophage lineage, shows that G-CSF reduces BM macrophage, coincident with HSPC mobilization. 29 Although these studies show monocyte/macrophage depletion enhances HSPC mobilization, the magnitude of response seen after G-CSF administration is at least three times greater than that seen following monocyte depletion, 28 indicating that G-CSF also acts on cells other than monocytoid cells. As anti-Gr-1 antibody recognizes both Ly6G and Ly6C epitopes and Ly6C is expressed on a subset of monocyes, 32 it is possible that anti-Gr-1 treatment during the G-CSF mobilization regimen also depletes some monocytes along with neutrophils. However, if monocytes/ macrophages are primarily responsible for G-CSF-induced HPC mobilization, then anti-Gr-1 antibody treatment during G-CSF mobilization should increase HSPC mobilization instead of decreasing it as we observed. More likely, mobilization occurs in concert coordinated by a balance between BM cell populations. Evidence is accumulating that disruption of mesenchymal lineage cell function within the endosteal niche has a key role in HSPC mobilization by G-CSF. 5, 16, 25, 26 Reversal of G-CSF-mediated reduction in osteolineage cells including progenitor cells and OB in anti-Gr-1 antibody treated neutropenic mice demonstrates that neutrophils are involved in G-CSF-mediated endosteal niche disruption. Furthermore, Ly6G-mediated neutrophil depletion, which does not ablate monocytes/macrophages, also afforded osteolineage cell protection similar to anti-Gr-1-mediated neutrophil depletion, demonstrating that neutrophils have a crucial role in endosteal niche degradation in response to G-CSF. As previous studies have shown that G-CSF-mediated monocyte/ macrophage depletion in BM is involved in HSPC mobilization, 27, 29 it is possible that simultaneous expansion of neutrophils and ablation of monocytes/macrophages in BM in response to G-CSF leads to maximum HSPC mobilization. Analysis of SDF-1 levels produced by OB in the presence of neutrophils clearly showed reduction in SDF-1 while others have shown that monocytes/ macrophages increase SDF-1 production. [27] [28] [29] Thus, together, these findings also suggest that the balance between neutrophil and monocyte/macrophage populations is likely required for the appropriate maintenance of the niche and that altering the balance of these populations disrupts the niche, a process that can be used for therapeutic benefit.
ROS have been implicated in osteolineage cell apoptosis. [33] [34] [35] G-CSF activates neutrophils to generate superoxide and other forms of ROS. 37, 38 Significant inhibition of osteolineage cell apoptosis in the presence of NAC suggests that neutrophilreleased ROS is involved, at least in part in the apoptosis of osteolineage cells. In support of our results, a recent finding shows that mice lacking ROS signaling have impaired HSPC mobilization in response to G-CSF. 36 In addition, recent studies have shown that spingosine-1-phosphate (S1P) is involved in HSPC mobilization 39, 40 and S1P has been shown to induce ROS production in neutrophils. 41 Therefore, it is possible that G-CSF may regulate ROS production in neutrophils via S1P signaling. That fact that inhibition of ROS production in neutrophils only partially reduces osteolineage cell apoptosis suggests the involvement of additional mechanism(s). Evidence that neutrophil proteases decrease OB proliferation 42 and induce apoptosis in endothelial cells, 43 argues that enhanced protease production by neutrophils in response to G-CSF may also be involved in osteolineage cell apoptosis. In addition, neutrophil proteases can activate the complement cascade that can lead to release of the bioactive lipids S1P and C1P (ceramide 1-phosphate) implicated in mobilization by G-CSF. 44 In conclusion, we provide evidence that neutrophil expansion, a physiological consequence of G-CSF administration, suppresses osteolineage cell populations in BM and impairs the production of HSC retention factors such as SDF-1, SCF and VCAM-1, thus disrupting the BM niche, leading to HSPC mobilization. These data clearly show that multiple cell populations are targeted by G-CSF and involved in altering the trafficking potential of HSPC. Although single-cell populations and mechanisms can lead to HSPC mobilization, optimal therapeutic mobilization is achieved in concert, and understanding the cells and signals involved will ultimately maximize therapeutic utility.
